COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced the U.S. Food and Drug Administration (FDA) granted...
ZIVO Bioscience, Inc., a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates derived from proprietary algal...
Amgen and BioLabs LA at the Lundquist Institute announced that Karma Biotechnologies has been awarded the second Amgen Golden Ticket in Southern California. Karma...
Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, announces that its Phase 2 COVID-19 trial for oral new drug Antroquinonol has achieved 100% recovery...
Laekna Therapeutics announced that the investigational new drug (IND) application of a combination therapy for the phase 1/2 clinical trial in patients with solid...
